Skip to content

Acupotomy for postoperative hypertrophic scar pain and pruritus after total knee arthroplasty: a randomized controlled trial

Acupotomy for postoperative hypertrophic scar pain and pruritus after total knee arthroplasty: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005425
Enrollment
Unknown
Registered
2021-12-19
Start date
2022-04-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scar after total knee replacement

Interventions

acupotomy group:Acupotomy combined with exercise rehabilitation

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) men or women aged 40–80 years; (2) patients met the diagnostic criteria of knee osteoarthritis [15]; (3) From 1 to 2 month after total knee arthroplasty, the wound healed well after suture removal, without abnormal ooze of blood or fluid; (4) Signed written informed consent.

Exclusion criteria

Exclusion criteria: (1) Preoperative diagnosis is not simple knee osteoarthritis, but combined with severe deformity, ligament injury around the knee, muscle strength abnormalities and other diseases; (2) Postoperative scar expands beyond the range of original lesions injured to surrounding normal skin; (3) Coagulation disorders; (4) Postoperative diagnosis is superficial incision tissue infection or deep incision tissue infection; (5) With severe physical and psychological illness that cannot coordinate the treatment; (6) Participation in other clinical researchers in the past 3 months.

Design outcomes

Primary

MeasureTime frame
WOMAC Pain Subscale;

Secondary

MeasureTime frame
VSS;NRS scale;WOMAC functional subscale;Dosage of loxolophen sodium tablets;WOMAC stiffness subscale;Knee range of motion;

Countries

China

Contacts

Public ContactShu-Ming Li
lishuming@bjzhongyi.com+86 010-52176050

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026